# PROCEPT BioRobotics Targets Positive Adjusted EBITDA in Q4 2026

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/49942
Published: 2026-11-06T07:43:44.000Z
Updated: 2026-11-06T07:43:44.000Z
Section: Business

> The company projects 2026 revenue of $390 million to $410 million and a full-year adjusted EBITDA loss of $30 million to $35 million.

PROCEPT BioRobotics is targeting positive adjusted EBITDA in Q4 2026, alongside a 2026 revenue outlook of $390 million to $410 million.

The company’s full-year adjusted EBITDA outlook is a loss of $30 million to $35 million. The positive target applies to the fourth quarter, while the loss range covers the year.